Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations

Clinical trial NCT01320397 · UNKNOWN

Trial details

NCT number: NCT01320397
Sponsor: RostaQuo S.p.A.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2011-05-01
Primary completion: 2012-07-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.